Open AccessEffect of mirabegron on erectile function in sexually active men with bothersome overactive bladder symptoms
Author(s) -
Tsung-Hsien Wu,
Yuan-Chi Shen,
WeiChia Lee,
HungJen Wang,
YaoChi Chuang
Publication year - 2020
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000208
Subject(s) - mirabegron , overactive bladder , medicine , urology , lower urinary tract symptoms , erectile function , erectile dysfunction , international prostate symptom score , prostate , alternative medicine , pathology , cancer
To evaluate the change of erectile function (EF) in sexually active male overactive bladder (OAB) patients treated with Mirabegron. Mirabegron, a selective β3 adrenoceptor agonist, approved for the treatment of OAB, has been reported to relax human and rat corpus cavernosum and might have beneficial effect on EF.